n-methyladenosine has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, S; Amaya, L; Broughton, JP; Cadena, C; Chang, HY; Chen, R; Chen, YG; Hur, S; Kasturi, SP; Kim, J; Pulendran, B; Verma, R | 1 |
| Ding, X; Li, D; Peng, Y; Wang, X; Wang, Y; Wu, Y; Yang, A; Yang, P; Yin, H; Yu, Y; Zhang, J; Zhang, R; Zhang, X | 1 |
2 other study(ies) available for n-methyladenosine and B16 Melanoma
| Article | Year |
|---|---|
N6-Methyladenosine Modification Controls Circular RNA Immunity.
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Adjuvants, Immunologic; Animals; CD8-Positive T-Lymphocytes; DEAD Box Protein 58; Female; HEK293 Cells; HeLa Cells; Humans; Immunity, Innate; Immunization; Interferon Regulatory Factor-3; Interferons; Lymphocytes, Tumor-Infiltrating; Melanoma, Experimental; Mice, Inbred C57BL; Polyubiquitin; Protein Multimerization; Receptors, Immunologic; RNA-Binding Proteins; RNA, Circular; Ubiquitination | 2019 |
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming.
Topics: Adenosine; Animals; Base Sequence; Cell Line, Tumor; Cell Polarity; Cell Proliferation; Cellular Reprogramming; Cytokines; Gene Deletion; Gene Expression Regulation; Lung Neoplasms; Macrophages; Melanoma, Experimental; Methylation; Methyltransferases; Mice, Knockout; Myeloid Cells; Neoplasm Metastasis; NF-kappa B; Programmed Cell Death 1 Receptor; Repressor Proteins; RNA-Binding Proteins; RNA, Neoplasm; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Tumor Microenvironment | 2021 |